Botanical species · safety record

Lilium brownii

The EFSA Compendium of Botanicals holds 3 constituent measurements for Lilium brownii. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Lilium brownii F.E.Br. ex Miellez

3Constituent measurements
0Safety records
3Cited sources
105Licensed products (Canada)

Also recorded as

Synonyms are carried from the source compendium. A species may be traded and studied under more than one name, which is exactly how a safety record gets lost.

Regulatory presence

Health Canada's Licensed Natural Health Products Database holds 105 licensed products naming Lilium brownii as a medicinal ingredient, matched on the exact Latin binomial. A licence records that a product met the regulator's requirements for sale in Canada. It is not evidence that the product works.

Extract types on licence

  • Dry
  • Fresh
  • decoction

Source material stated

  • Bulb
  • Bulb extract
  • Lilium lancifolium - Bulb
  • Lilium pumilum - Bulb
  • New material

What the records describe

Constituents measured

  • Saponins1
  • Steroidal alkaloids1
  • Steroidal glycosides1

Plant parts

  • Bulb3
  • clove3

Preparations

  • Solvent extraction3

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

SubstancePlant partPreparationConcentrationAnalytical methodSource
SaponinsBulb / cloveSolvent extractionStandard Chromatographic tests (paper- thin layer- and column chromatography)Resolve DOI
Steroidal glycosidesBulb / cloveSolvent extractionLC-GC-MSResolve DOI
Steroidal alkaloidsBulb / cloveSolvent extractionNuclear Magnetic Resonance (NMR)No resolvable identifier

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

  1. Hong, Xiao-Xiao., Luo, Jian-Guang., Guo, Chao., Kong, Ling-Yi. New steroidal saponins from the bulbs of Lilium brownii var. viridulum. Carbohydrate research, 2012, vol. 361, p. 19-26. DOI
  2. Zhu, Mengdi., Luo, Jianguang., Lv, Huawei., Kong, Lingyi. Determination of anti-hyperglycaemic activity in steroidal glycoside rich fraction of lily bulbs and characterization of the chemical profiles by LC-Q-TOF-MS/MS . Journal of functional foods, 2014, vol. 6, p. 585-597. DOI
  3. MIMAKI, Y., SASHIDA, Y. STEROIDAL SAPONINS AND ALKALOIDS FROM THE BULBS OF LILIUM-BROWNII-VAR-COLCHESTERI . Chemical & pharmaceutical bulletin, 1990, vol. 38, no. 11, p. 3055-3059.

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue